Araştırma Makalesi

Comparison of visceral adipose tissue in patients with autonomous cortisol secretion and patients with the nonfunctional adrenal masses

Cilt: 48 Sayı: 3 30 Eylül 2023
PDF İndir
EN TR

Comparison of visceral adipose tissue in patients with autonomous cortisol secretion and patients with the nonfunctional adrenal masses

Abstract

Purpose: This study aimed to explore the impact of continuous autonomous cortisol secretion on visceral (VAT), abdominal subcutaneous (SAT) adipose tissue, and total body fat. Materials and Methods: A total of 57 patients (36 female, 21 male) with adrenal masses, referred to our single center, were included in this study. Among them, 31 patients had adrenal cortical carcinoma (ACS) and 26 had nonfunctional adrenal mass (NFAM). Hormonal evaluation was conducted for all patients. Measurements of total, visceral, and subcutaneous adipose tissue were performed using 3.0 T magnetic resonance imaging (Ingenia, Philips Medical Systems, Best, The Netherlands). Results: Mean age, gender distribution, and body mass index (BMI) were comparable between patients with ACS and NFAM. Patients with ACS exhibited higher volumes of both total (422.1±131.3 vs. 346.2±86.0 cm3) and visceral adipose tissue (199.9±77.3 vs. 160.6±60.8 cm3) compared to those with NFAM. Incidence rates of diabetes mellitus and hepatosteatosis were similar in both groups. Subcutaneous adipose tissue volumes, visceral-to-subcutaneous ratio, and visceral-to-total fat ratio showed no significant differences between the two groups. Conclusion: Patients with ACS demonstrated increased total and visceral fat tissue volumes compared to NFAM patients matched for gender, age, and BMI. This observation may elucidate the potential influence of continuous mild autonomous cortisol secretion in ACS patients. Such findings could serve as indicators of heightened cardiovascular risk among ACS patients.

Keywords

Autonomus cortisol secretion , nonfunctional adrenal incidentalomas , visceral adipose tissue , magnetic resonance imaging

Kaynakça

  1. Delivanis DA, Athimulam S, Bancos I. Modern management of mild autonomous cortisol secretion. Clin Pharmacol Ther. 2019;106:1209-21.
  2. Bancos I, Alahdab F, Crowley RK, Chortis V, Delivanis DA, Erickson D et al. Therapy of Endocrine Disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing’s syndrome: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175:283-95.
  3. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A et al. Management of adrenal incidentalomas: European Society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. 2016;175:1-34.
  4. Debono M, Bradburn M, Bull M, Harrison B, Ross R.J., Newell-Price J. Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J Clin Endocrinol Metab. 2014;99:4462–70 .
  5. Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing’s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014;2:396–405.
  6. Sbardella E, Minnetti M, D’Aluisio D, Rizza L, Di Giorgi MR, Vinci F et al. Cardiovascular features of possible automous cortisol secretion in patients with adrenal incidentaloma. Eur J Endocrinol. 2018;178:501-11.
  7. Delivanis DA, Iñiguez-Ariza NM, Zeb MH, Monyagh MR, Takahashi N, Mckenzie T et al. Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas. Clin Endocrinol (Oxf). 2018;88:209-16.
  8. Constantinopulos P, Micholoi M, Kottorou A, Habeos I, Psyrogiannis A, Kalfarentzos F et al. Cortisol in tissues and systemic level as a contributing factor to the development of metabolic syndrome in severaly obese patients. Eur J Endocrinol. 2015;172:69-78.
  9. Kumari M, Chandola T, Brunner E, Kivimaki M. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab 2010;95:4415–23.
  10. Sakurai T, Ogasawara J, Kizaki T, Sato S, Ishibashi Y, Takahashi M et al. The effects of exercise training on obesity-induced dysregulated expression of adipokines in white adipose tissue. Int J Endocrinol 2013;2013:1-28.

Kaynak Göster

MLA
Pişkin, Ferhat Can, vd. “Comparison of visceral adipose tissue in patients with autonomous cortisol secretion and patients with the nonfunctional adrenal masses”. Cukurova Medical Journal, c. 48, sy 3, Eylül 2023, ss. 911-8, doi:10.17826/cumj.1319639.